Coherently with this hypothesis, PGC-1α null mice are prone to the development of neurodegeneration under treatment with PD-related drugs and upregulation of PGC-1α in mouse model of neurodegeneration ameliorates disease's symptoms [37, 39, 40]. This evidence concerns the gene PPARGC1A and Parkinson disease.